Petros Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Petros Pharmaceuticals has a total shareholder equity of $12.5M and total debt of $8.0M, which brings its debt-to-equity ratio to 64.2%. Its total assets and total liabilities are $33.8M and $21.3M respectively.
Key information
64.2%
Debt to equity ratio
US$8.01m
Debt
| Interest coverage ratio | n/a |
| Cash | US$13.34m |
| Equity | US$12.48m |
| Total liabilities | US$21.32m |
| Total assets | US$33.80m |
Financial Position Analysis
Short Term Liabilities: PTPI's short term assets ($20.4M) exceed its short term liabilities ($10.8M).
Long Term Liabilities: PTPI's short term assets ($20.4M) exceed its long term liabilities ($10.5M).
Debt to Equity History and Analysis
Debt Level: PTPI has more cash than its total debt.
Reducing Debt: PTPI had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PTPI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: PTPI has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 21.8% each year.